USFDA concludes GMP inspection at Gland Pharma’s Visakhapatnam facility

31 Jul 2023 Evaluate

United States Food and Drug Administration (USFDA) has concluded Good Manufacturing Practice (GMP) inspection at Gland Pharma’s VSEZ Sterile Oncology facility at Visakhapatnam. The said inspection has conducted between July 20, 2023 and July 28, 2023. The inspection was concluded with (Zero) 483 observations and a classification of No Action Indicated (NAI).

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in many countries.

Gland Pharma Share Price

1677.00 -44.65 (-2.59%)
23-Jan-2026 15:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 885.00
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×